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Myogenesis is a tightly regulated process resulting in unique structures called 
myotubes or myofibers, which compose skeletal muscle. Myotubes are 
multi-nucleated fibers containing a functional unit composed of cytoskeletal proteins 
called the sarcomere. The specific arrangement of these proteins in the sarcomere 
works to contract and relax muscles. During embryonic and post-embryonic 
development, fluctuations in expression of growth factors throughout the program 
account for the dramatic structural changes from cell to mature muscle fiber. In vivo, 
these growth factors are strictly spatiotemporally regulated according to a ‘myogenic 
program.’  In order to assess the dynamics of protein expression throughout this 
program, we conducted a time course study using the mouse myoblast cell line 
C2C12, in which cells were allowed to differentiate and insoluble protein fractions 
were collected at seven time points. The insoluble protein fraction accounts for 
cytoskeletal proteins, involved in the dramatic remodeling of cells. In order to 
discover influence of growth factors on protein expression, a similar time course was 
conducted with the addition of growth factors (serum) at specific time points after 
induction of myogenesis. The cells were allowed to differentiate through the time 
course and the detergent- insoluble protein fractions were collected. Proteins were 
separated according to their eletrophoretic mobility using SDS-PAGE and were  
identified using LC-MS/MS. Proteins were then functionally annotated using Gene 
Ontology (GO) terms. Analysis of protein expression during in vitro myogenesis 
shows progression of the myogenic program. Furthermore, a targeted gene 
expression study was conducted using reverse-transcriptase quantitative PCR. 
Expression of the sarcomeric proteins actin, myosin, and titin also fluctuated 
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Movement is essential for all life; it allows us to obtain necessary resources and 
sustain vital biological functions, such as breathing. At the basis of the ability to 
move we find skeletal muscles, which are composed of a series of complex structures 
working in concert to provide both voluntary and involuntary contraction. The 
intricacy of muscle tissue indicates an extensive developmental program.  
Muscle cells, also known as myocytes, are highly specialized and multinucleated 
due to the fusion of precursor cells known as myoblasts. These cells appear striated 
due to an arrangement of intracellular structures, known as myofibrils. Myofibrils are 
composed of thick and thin filaments, with each filament type containing different 
proteins serving their respective functions during muscle contraction. These fibers are 
arranged in a highly unique structure known as the sarcomere, the smallest unit of 
contraction.The thin filaments, which compose the Z-line of the sarcomere, are 
predominately actin protein. The thick filament, which forms the M-line of the 
sarcomere, is composed of the motor protein myosin. Through a cascade of 
molecular binding and conformational changes, the thousands of tandem sarcomeres 
found in muscle, shift together to contract the tissue to produce movement. Though 
muscle function has been well studied, the molecular mechanisms behind developing 
this elaborate and diverse tissue have not all been elucidated.      
1.2. Myogenesis  
Myogenesis, the process of muscle development, as most developmental 
pathways, is complex, tightly regulated, and continues throughout an organism’s 
lifetime. Myogenesis occurs in multiple and overlapping phases initiated by 
spatiotemporal cues from cascading transcription factors. The major events occurring 
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throughout the process include specification of cell lineage, proliferation, migration, 
and differentiation. Even differentiation is further organized into a specified time line 
depending on the type of progenitor cell entering this phase (Rossi,Messina 2014). 
As is well referenced, skeletal muscle is a heterogenous tissue with several different 
fiber types to serve its wide array of functions. Terminal differentiation and protein 
composition of these fibers differ, accounting for increased complexity in the 
signaling transduction pathways (Meressi et al. 2007)   
1.2.1 Molecular Embryonic Myogenesis 
Myogenesis is a conserved process with studies comparing several vertebrate 
model organisms: zebrafish, mice, rats and chickens. In fact, the basic 
helix-loop-helix (bHLH) motif was first characterized in muscle specific regulatory 
factors (MRF’s). The first protein in the family to be discovered was the MyoD 
transcription factor. In 1987 Davis et al. transfected cDNA from mouse myoblasts 
into fibroblasts, and they proceeded to fuse into myotubes (Davis et al. 1987). It was 
hypothesized this cDNA activated loci in the genomic DNA that could establish a 
myogenic lineage regardless of original cell program (Choi et al.990). They were 
able to identify a characteristic DNA binding domain that would go on to identify 
other MRF’s, such as Myf5, Myogenin (Myog), and Mrf4. MyoD and Myf5 are both 
critical in skeletal myoblast lineage specification and are activated by the 
morphagens sonic hedgehog (Shh) and wingless1 and 3 (wnt1 and wnt3), and the 
paired-homeobox 3 transcription factor (Pax 3). Another paired-homeobox 
transcription factor, Pax7 is found upregulated with myogenin in terminal 
differentiation, although the exact mechanism of Pax7 function is unknown (Parker et 
al. 2007).  MRFs and the Pax transcription family work with a multitude of other 
proteins in well-known signaling pathways to push embryonic myoblasts out of the 
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cell-cycle and into the proper localization and mature myocyte. (Braun, Gautel, 2011) 
1.2.2. Myogenesis in C2C12 cells 
C2C12 cells are a mouse embryonic myoblast cell line that have been used 
extensively by researchers to investigate properties of muscle development. Although 
the myogenic lineage has been established in these cells studies have shown that the 
major transcription factors from early myogenesis can be traced to some extent (Diel 
et al 2008, Rios et al 2001). Researchers can then take a closer look at secondary 
myogenesis and terminal differentiation. 
Traditionally cells are obtained commercially and proliferated in culture flasks 
using a nutritious medium supplemented with a high percentage of a growth serum, 
such as fetal bovine serum (FBS). Myoblasts are then triggered to differentiate by 
reducing the percentage of growth serum, thereby reducing growth factors and 
mitogens, after which they begin to fuse and elongate. By approximately 6 days 
post-differentiation, mature myofibers are formed in culture and by day 12, fully 
function muscle cells are present (Kislinger et al. 2005). This simple, yet effective 
methodology has allowed researchers to externally alter the myogenic program by 
various technique to investigate specific aspects of the program (Blau, Epstein, 
1979).  
1.3 Sarcomeric Proteins 
Myogenic cell populations, in vivo and in vitro, undergo extensive structural 
changes throughout their development to mature muscle fibers. Progenitor cells fuse 
together and subsequently go through cytoskeletal remodeling. Next cells adhere to 
the extracellular matrix and elongate to form the striated pattern characteristic of 
muscle tissue (Rui et al. 2010). Although several proteins are involved in making the 
final structure, we are most interested in the main proteins involved in the basic 
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contractile unit, the sarcomere. Interestingly, much research has been done on the 
anatomical and molecular processes in myogenesis; however the assembly of the 
sarcomere is still poorly understood (Rui et al. 2010). The mechanism of function of 
the sarcomere is well known; however the foundation of some myopathies still elude 
us and are continually being investigated. Perhaps, a foundation in 
sarcomereogenesis may provide crucial details. 
1.3.1 Titin 
The largest protein known to man, so far, is titin, also known as connectin, and is 
the third main protein involved in muscle contraction after actin and myosin. Titin is 
coded for by the single gene TTN; however, this gene contains a total of 363 exons 
and is known to undergo alternative splicing to produce several isoforms of titin 
expressed variably in tissues (Guo et al 2009). One isoform known as N2A was 
found to always be expressed in skeletal muscle. This multidomain protein is the 
third most abundant in the sarcomere and serves several functions.  
Titin spans the half the entire sarcomere the N-terminus ending at the Z-line and 
the C-terminus at the M-line. The length of the protein is included in two prominent 
sarcomeric regions known as the I- band, describing thin filaments not overlapped by 
thick filaments, and the A band, which spans the thick filaments (Tskhovrebova, 
Trinick, 2004). It is well documented that the structure of titin changes drastically at 
the A/I band junction. The predominant domains found in the I band regions are 
tandem immunoglobulin (Ig) domains connect by a domain dominated by proline, 
glutamate, valine, lysine (PEVK) motif. This region is thought to give elasticity to 
the sarcomere, as the bound thin filaments contract. For example, the stiff PEVK 
motif is modulated by calcium ions, crucial for muscle contraction. Continuing 
through the A-band, fibronectin-3 and Ig domains repeated corresponding to the thick 
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filaments ending with a kinase domain at the M-line (Tskhovrebova, Trinick, 2004). 
The corresponding domains allow titin to bind myosin in the thick filament 
stabilizing the structure. However, these domains are conserved and allow for the 
interaction of titin with other proteins (Eilersten et al 1994). 
Titin has been found to play a role in myopathies and dystrophies. For example, 
Walker et al initially worked on mysethia gravis (MG), a nueromuscular autoimmune 
disorder resulting in weakening muscles. They found a subset of patients presented 
with Autoimmune Rippling Muscle disease (ARMD), exibiting involuntary muscle 
spasms. Walker et al eventually found that these patients possessed antibodies against 
titin N2A (Watkins et al. 2006). These autoantibodies were found against the region 
in which titin and myosin overlap and near the PEVK motif, possibly accounting for 
altered sarcomere contraction and phenotypic symptoms.  
1.3.2 Myosin 
Although the actin, the most abundant of the sarcomeric proteins, gives rise to 
the structure, myosin is the main component in driving contraction. Known as 
myosin heavy chains (MYH), myosin is a motor protein involved in several cellular 
processes such as cytokinesis, vesicular transport, and motility (Weiss et al 1999). 
Those are most concerned with are Myosin II or “conventional” mysoins forming the 
thick filaments of the sarcomere. These proteins have an ATPase region from which 
they utilize the energy generated from the hydrolysis of ATP to contract the 
sarcomere.  
There are five isoforms of myosin that are differentially expressed based on 
developmental time and muscle fiber type. These include MYH 3, an embyronic 
isoform, MYH8, a perinatal isoform, MYH 2, MYH 1, MYH4, adult isoforms, and 
lastly MYH7, a slow isoform. Genes encoding these isoforms are found in clusters 
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along chromosomes 11 in mice and conserved along chromosome 17 in humans 
(Weiss et al 1999). The isoforms expressed post-natally give rise to the variability of 
contractile functions and diversity in muscle fibers. Each isoform is expressed 
according to different external stimuli, such as physical activity (Pandorf et. al 2006, 
Biressi et al 2007). A shift can occur as muscles adapt to either slower or faster 
contractile properties. For example a shift in expression from MYH2 to MYH1 to 
MYH4, fast-twitch myosin heavy chain, can occur with increased muscle use. The 
transcriptional regulation of this shift has not been elucidated.  
1.4 Proteomics 
Proteomics was defined by Wu et al. as a “collective study of all measured 
proteins of cells in a given condition” (Wu et al. 2002). The study of “-omics” and 
other high through-put data acquisition techniques in recent years has been 
particularly valuable to developmental studies, such as the exploration of muscle 
development. As illustrated previously, the process is a concert of genes, proteins and 
small molecules with most serving several functions. Proteomics and other 
high-throughput gene expression data can give us a snapshot in time of processes 
taking place within a living animal or cell culture (Wu et al. 2002). Pertaining to 
proteomics specifically, the presence and abundance of an identified protein is 
indicative of gene expression patterns taking place within the cells. By layering 
proteomic data from several time points, a clear picture of events is illustrated 
throughout the development program.  
Furthermore with the rise of big data sets comes the development of databases 
and tools for structural, evolutionary, and functional annotation and visualization of 
genes and gene products. In one example, Kislinger et al uses the Gene Ontology 
Consortium classification system to associate their identified protein products 
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collected from their C2C12 cell lysate with biologically relevant terms (Ashburner et 
al. 2000). The functional clustering of hundreds of identified proteins illustrated the 
enrichment of mitotic, structural, and metabolic proteins at expected time points 
throughout myofiber development (Kislinger et al 2011)\. 
1.5 Aims 
In this study we aim to track the fundamental events of myogenesis using C2C12 
myoblasts over time with a focus on cytoskeletal proteins and their role in 
remodeling to form these unique cells. We take both a global approach in using 
proteomics to define particular events and a targeted approach in using 
reverse-transcriptase quantitative PCR (RT-q-PCR) against the prominent sarcomeric 
proteins actin, titin, and myosin. Perhaps this may provide insight to sarcomeric 
assembly.  
These approaches will give us a comprehensive look inside myogenic cellular 
development, as other studies have previously. However, we also attempt to define 
the role of growth stimulating factors from growth serum, such as FBS, used during 
in vitro studies. We have added back high growth serum media at specific time points 
after cells have been “pushed out” of proliferation using low growth serum, as is 
traditional. We will look at this effect through proteomics and RT-q-PCR and 
perhaps see a resetting of the myogenic program.   
1.6 Hypothesis 
Although myogenesis is tightly regulated, growth serum contains mitogens 
which can activate several signaling pathways. Our approach to “add-back” these 
mitogens, along with other growth factors which can affect development, has proved 
novel. Collective literature review has defined time points at which prominent stages 
occur during the developmental program. Utilizing this knowledge, we plan to 
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investigate the role of these external signaling factors by making them available to 
the cells once more. We hypothesize that the addition of the media supplemented 
with a high percentage of FBS will reset the myogenic program, and cause at least a 

























2.1 Cell Culture 
C2C12 mouse myoblast cell line bought from ATCC (Manassas, VA) was used 
in all proceeding experiments. Cells were cultured using traditional adhesion culture 
methodology. 1 mL vial of cells was defrosted in a 37ºC water bath, and gradually 
mixed with Dulbeco’s Modified Eagle Media (DMEM) supplemented with 20% 
Fetal Bovine Serum (FBS) and 1% Ampicillin (High Serum Growth Media). Cells 
were grown in an incubator at 37ºC with 5% CO2 until an observed confluency of 80% 
to 90%. Cells were treated with 1x 0.05% Trypsin-0.53 mM EDTA (Corning Life 
Sciences, Manassas, VA) pelleted in a 15 mL conical tube and reseeded at 1mL in 
two separate culture flasks. The cells were once again grown up to observed 
confluency of 80-90%.  
Cells from each flask were pelleted again and reseeded into triplicates of 25cm3 
flasks representing time points designated:  T= 0 Days, T= 2 days, T= 4 days, T= 6 
days, T= 8 days and T= 12 days. Cells were proliferated in each flask to 80-90% 
observed confluency with high growth serum then triggered into differentiation with 
DMEM supplemented with only 1% FBS and 1% ampicillin denoted as low growth 
serum media. Cells from triplicate flasks designated T= 0 were collected, pelleted 
and stored in a cryogenic solution. Remaining cells were fed low growth serum 
media until the time points designated on each set of flasks after which cells were fed 
high growth serum media. These cells were all grown and harvested after 13 days, 
from the day differentiation was triggered. This time course was carried out twice; 
but during the second time course, T= 0 days was replaced with triplicate control 
flasks. These control flasks were grown to and harvested at 13 days, but no high 
growth serum was added back (See Appendix 3 for time course calendars). 
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2.2 Protein Collection 
Cell lysate was collected according to protein solubility in detergent to produce 
soluble and insoluble fractions. All flasks containing cells from the first time course 
were collected separately at Day 13, trypsinzed then treated with 1 mL isotonic wash 
buffer followed by 1 mL buffer containing triton-x-100. Buffer now containing 
detergent- soluble protein fraction was poured out of the culture flask into microfuge 
tubes and stored at -80ºC. Remaining lysate, in each flask was treated with 1 mL of 
1X SDS buffer and rocked gently on ice for 5 min or until DNA degraded completely. 
This detergent- insoluble protein fraction was collected in microfuge tubes and stored 
at -80ºC.   
2.3 SDS-PAGE and Gel Analysis 
Our interest centered around cytoskeletal protein investigation, therefore only 
proteins in the detergent-insoluble fraction were used in downstream applications 
Samples of extracted protein treated with 1x SDS were thawed and 10µl from all 
triplicates in each time point, as well as bovine serum albumin (BSA) standard, were 
loaded into two precast 12% polyacrylamide gels, as (Bio-Rad, Hercules, CA) and 
ran with 1X tris-glycinde-SDS (TGS) running buffer. The powers source was set a 
constant 40 A/gel and ran for an average of 30 minutes. This process was repeated 
several times with varying loading volumes to find optimum volume.  
Gels were then visualized using Coomassie Brilliant Blue staining. Gels were shaken 
over night with filtered Coomassie stain (Fisher Scientific, Pittsburgh, PA) and a 
protein fixing buffer. Gels were then treated with buffers denoted as high and low 
destain. These were used alternately until gel became translucent and proteins bands 
were visible. Gel image was then captured and scanned onto the computer using the 
Pharos FX system (Bio-Rad, Hercules, CA), and analyzed using the software 
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Quantity One (Bio-Rad, Hercules, CA) according to the quick start guide included in 
the program. 
2.4. LC- MS/MS and Proteomic Analysis 
 Protein identification was necessary to describe specific events in the in vitro 
myogenic program, and to specify the presence of cytoskeletal proteins of interest. 
Triplicate samples from each time point were pooled together and 12 µl of pooled 
sample from each time point were loaded in a precast 12% polyacrylamide gel 
(Bio-Rad, Hercules, CA) and run as described previously. Triplicates were pooled in 
order to increase abundance and diversity of proteins at each time point for higher 
resolution detection. The gel was stained with Coomassie Brilliant Blue and proteins 
were fixed in the gel as described above.  
Eight gel bands were selected (Fig. 2) to be cut out to be sent to Ohio State 
University Mass Spectrometry and Proteomics Facility for identification. Four band 
regions at molecular weights of:  >212 kDa., ~212 kDa, ~45 kDa and ~18 kDa at 
days 0 and 6 were chosen and sent. Proteins were partially sequenced using 
capillary-liquid chromatography tandem mass spectroscopy (LC-MS/MS). The 
sofware MASCOT (Matrix Science, London, UK) was used for sequence 
identification and protein abundance. UniProtKB/Swiss-Prot protein database ID’s, 
emPAI abundance values, scores and partial alignments were sent back. Further 
proteomic analysis was done using various online programs such as Database for 
Annotation, Visualization and Integration Discover (DAVID), Gene Ontology 
Consortium, and MetaboAnalyst to functionally annotate and visualize data.  
2.5. RNA extraction, RT-qPCR, and Statistical Analysis  
Cells from the second time course were collected at day 13; each flask was 
separately trypzinized, pelleted and stored at -80ºC. At a later time, total RNA was 
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extracted from each cell pellet using RNeasy Mini Kit (Qaigen, Valencia, CA) 
according to kit protocol. RNA concentrationand quality were determined using a 
Nanodrop Spectrophotometer (ThermoScientific, Waltham, MA). 
Reverse transcriptase quantitative PCR (RT-qPCR) was then carried out using 
the iTaqTM Universal SYBR® Green One-Step kit (Bio-Rad, Hercules, CA). Each 
reaction in a 96-well plate contained:  0.2 µl reverse transcriptase, 2 µl F primer (10 
µM), 2 µl R primer (10 µM), 3.75 µl nuclease-free water, 10 µl Sybr green, 2 µl 
RNA (150 µg). Primers were designed based on previous experimentation in this lab; 
but MYH4 and MYH8 were based on Zhou et al.’s work (See Table 1 below) (Zhou 
et al 2010). Reactions took place on the iCylcer iQtm Real-Time PCR detection 
system (Bio-Rad, Hercules, CA) and accompanying software. Finally, statistical 
analysis on amplification data was carried out using DART-PCR excel-base analysis 
(Peirson et al. 2003). 
 
Table 1. Primer sequences 
 
Gene Forward  Reverse 
Alpha, 
Actin-1  
5’ AGGACCTGTATGCCAACAACGTCA 3’ 5’ TCAACATCTGCTGGAAGGTGGACA 3’ 
Titin 
N2A 
5 ’CCTGAGGACCTGGAAGTCAA 3’ 5’ AGTACCAATGAGGCGGCTTT 3’ 
MYH4 5’ CACCTGGACGATGCTCTCGAG 3’ 5’ GCTCTTGCTCGGCCACTCT 3’ 










3. RESULTS  
3.1.Introduction 
 
Firstly, the cytoskeletal proteome was analyzed using SDS-polyacrylamide gel 
eletrophoresis (SDS-PAGE) then LS/MS-MS identification. Both time point and 
molecular weight were criteria to find proteins of interest; however, a complete 
profile of the dynamics of the proteome was also illustrated using functional 
annotation. These results were compared to both the work of Kislinger et al. who 
used similar approaches. The addition of a high growth serum media, such used in 
proliferation, post initiation of terminal differentiation provided a novel aspect to our 
proceedings.  
Inspired both by previous work in this lab and our proteomic findings, a directed 
gene study was conducted using reverse transcriptase-quantitative polymerase chain 
reaction (RT-qPCR). Most importantly, genes targeted are essential to structure and 
function of skeletal muscle, and can be used as developmental temporal cues.  
3.2. Separation of Proteins through SDS-PAGE  
Upon collection of cell lysate from each of the twenty-one cultures, two separate 
types of samples were collected: a detergent-insoluble protein sample and 
detergent-soluble protein sample. Each sample fraction denotes the solubility of 
proteins in the detergent, triton-x-100. Our interest is primarily in cytoskeletal 
proteins which are predominantly found in the detergent-insoluble fraction; therefore 
our analyses only concerned the samples collected from this fraction. 
Proteins in the detergent-insoluble lysate for each culture were separated through 
SDS-PAGE. Firstly, biological triplicates at each time point were run next to one 
another to observe consistent banding patterns for each time point. Upon confirming 
consistency of samples in a single time point, a single SDS-PAGE was conducted 
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containing all time points for a reliable time course comparison. Banding patterns 
between lanes, indicating time points after high serum was added, show various shifts 
in protein density. Prominent bands appear within each lane and at the same 
electrophoretic distance between lanes. For example, a prominent band can be 
observed between 66.2- 45.0 kDa in all lanes. However the pronounced prominence 
of the band at Day 6 is a result of contamination of a BSA quantification standard. 
The bands also appear in the well region of each lane indicating the presence of 
proteins too large to migrate through 12% polyacrylamide. Gel was analyzed using 
QuantOne software (Bio-Rad, Hercules, CA) which showed overall varied protein 



















Fig 1. Protein profile of detergent 
insoluble cell lysate. 
(A) Gel image from 12% SDS-PAGE 
of detergent- insouble protein 
fraction. Lane represent time points 
after add-back of high-serum; 
molecular weight standards present 
on both sides. Band densities vary 
across time points. (B) Protein 
abundance across migration distance. 
X-axis represent protein counts, 
y-axis represent Rf values. Each color 
represents a lane, representing a time 
point after add-back of high serum. 
High abundance found at >116 kDa 
and at 45 kDa.    
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3.3 Proteomic analysis 
Further investigation of the proteome required identification of proteins present 
in the detergent-insoluble fraction of the first set of cultures. Band regions were 
selected from T= 0 days and T= 6 days across molecular weights (Table 2). Band 
regions at >212 kDa and ~212 kDa were selected with the intent of identifying titin 
and myosin. Band regions at ~45 kDa and ~18 kDa were chosen with the intent of 
identifying actin isoforms. Bands were cut from an electrophoretic gel and sent to 
Ohio State University Mass Spectrometry and Proteomics Facility for LC/MS-MS 
processing, and preliminary bioinformatic analysis. T= 0 days represents high growth 
serum add-back 24 hours after differentiation was triggered; and T= 6 days represents 
high growth serum add-back six days after differentiation was triggered. Although 
cells were grown to thirteen days, the most dramatic observed morphological changes 
occur through ~ Day 6 when elongated myotubes are present in the culture (Kislinger 
et al. 2005). Although, high serum was added back, we still observed these distinct 
morphological changes of cells in culture.   
Using the MASCOT protein search engine (Matrix Science, London, UK), Ohio 
State University Mass Spectrometry and Proteomics Facility identified a total of 80 
different proteins from Day 0 and 130 different proteins from Day 6 (A5). All protein 
band regions from both time points were selected from the same SDS-PAGE 











Fig 2/Table 2. Gel Band Region Excision for LC-MS/MS analysis, high 
growth serum conditions. SDS-PAGE was performed on insoluble protein fraction 
from high serum treatment. Portions (indicated in red for Day= 0 and green for Day= 
6) of the gel containing proteins of interest were sent for sequencing using 
LC-MS-MS. SDS-PAGE gel sampling regions are indicated by boxes (Band regions 
1-4 for both day 0 and day 6). 
3.4. Functional Annotation 
High-throughput data sets can be challenging to parse through in a meaningful 
way. In order to identify specific events in the myogenic program and monitor major 
changes during these events, identified proteins from each time point were 
functionally annotated using the online program Database for Annotation, 
Visualization and Integration Discovery (DAVID).  The analysis included both 
KEGG biological pathway identification and Gene Ontology (GO) (Ashburner et al 
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2002) term enrichment (p>0.05), allowing us to elucidate the global dynamics of the 
cell culture.  
Concerning Day 0, 76 of the 80 identified proteins were mapped onto separate 
GO annotations specific to mouse with significance (p>0.05); in Day 6, 119 of 130 
proteins were mapped onto separate GO annotations specific to mouse with 
significance (p>0.05). Each protein was mapped onto at least one or more of the three 
GO categories: biological process, cellular component, molecular function. DAVID 
yielded hundreds of GO terms corresponding to events reflecting myogenic 
development such as cytoskeleton, proteosome, motor activity, and skeletal muscle 
contraction. 
3.4.1. Myogenic Program  
Upon induction of differentiation by growth factor withdrawal, a dramatic shift 
in cellular processes occurs accompanied with an increase in intracellular signaling. 
At this stage, embryonic myoblasts exit the cell cycle and begin drastic structural 
remodelling. Among the enriched GO terms included histones, DNA binding, RNA 
binding, and chromatin indicating an upregulation of transcriptional regulation. For 
example, core nuclesosome components such as histones 2 and 3 and chromatin 
remodeling factors such as chromodomain-helicase-DNA binding protein 5 were 
found throughout the time course. Accompanying these basic transcription regulatory 
factors is the upregulation of downstream signaling proteins, such as Ras 
GTPase-activating-like protein and A-kinase anchor protein 2 further indicative of a 
changing landscape within the cells. 
However of the 210 identified proteins, cytoskeletal factors dominated the 
proteome. GO terms enriched include basement membrane, cytoskeleton, adherens 
binding all under the umbrella GO term striated muscle tissue development. 
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Subterms even included sarcomere, actin binding, and microfilament motor activity. 
Specific proteins include organizational factors laminins, nidogen 2, filamin-A,-B,-C, 
fibronectin, and various isoforms of actin. In fact, the most abundant proteins were in 
the data were Actin, cytoplasmic 1 and Actin, alpha skeletal muscle. Adhesion 
proteins such fibronectin and talin-1, -2. Finally, crucial to cell remodelling are 
proteases; proteosome subunits and proteases such as 26S protease regulatory subunit 
and proteasome-associated protein ECM29 homolog are also enriched throughout the 
terminally differentiating proteome. The comprehensive function of these proteins 
was mapped onto the KEGG biological pathways denoted as “skeletal muscle 

































Table 3. Transcription regulatory proteins. (A) Proteins identified in 
transcriptional regulation. “+” represents presence of protein at Day 0 and Day 6 , 
and “-” represents absence of protein at Day 0 and Day 6. (B) GO terms associated 
with these particular proteins. P-values and enrichment scores signify significance of 
terms. Analysis generated by DAVID.  
A 
Uniprot ID Day 0 Day 6 Protein 
H2A2B_MOUSE + + Histone H2A type 2-B 
H2A1F_MOUSE + +  Histone H2A type 1-F 
H3C_MOUSE + +  Histone H3.3C 
H32_MOUSE - +  Histone H3.2  
H31_MOUSE - +  Histone H3.1 
HNRPD_MOUSE + +  Heterogeneous nuclear ribonucleoprotein 
TADBP_MOUSE + +  TAR DNA-binding protein 43 
DNJA2_MOUSE - +  DnaJ homolog subfamily A member 2 
CHD5_MOUSE - +  Chromodomain-helicase-DNA-binding protein 5 
RBP2_MOUSE - +  E3 SUMO-protein ligase RanBP2 
PRP8_MOUSE - +  Pre-mRNA-processing-splicing factor 8 
TPR_MOUSE + +  Nucleoprotein TPR 
B. 
Most proteins were found to overlap at both time points, as expected due to the 
multi-layered process of myogenesis. However, for myocytes to become functional, 
an alteration in metabolic processes needs to occur to provide energy for muscle 
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contraction. There were 73 proteins found to be exclusive to day 6, many of which 
are associated with mitochondrial metabolism and development of biochemical 
processes. Oxidative phosphorylation, ATP synthesis coupled proton transport and 
generation of precursor metabolites and energy were highly enriched according to 
GO annotations. Key metabolic enzymes such as alpha-enolase, creatine kinase, 
citrate synthase, and cytochromes composing the electron transport chain are 
expressed at Day 6. Coupled with this data is the presence of components of calcium 
ion channels, such as voltage-dependent calcium channel subunit alpha2/d; calcium is 




















Table 4. Metabolic Process Proteins.  (A) Proteins identified in metabolic 
processes. “+” represents presence of protein at Day 0 and Day 6 , and “-” represents 
absence of protein at Day and Day 6. (B) GO terms associated with these particular 
proteins. P-values and enrichment scores signify significance of terms. Analysis 
generated by DAVID   
 
A.  
Uniprot ID Day 0 Day 6 Proteins 
PPIA_MOUSE + +  Peptidyl-prolyl cis-trans isomerase A  
QCR2_MOUSE + +  Cytochrome b-c1 complex subunit 2, mitochondrial 
ATPB_MOUSE - +  ATP synthase subunit beta, mitochondrial 
QCR1_MOUSE - +  Cytochrome b-c1 complex subunit 1, mitochondrial 
TFR1_MOUSE - +  Transferrin receptor protein 1 
NSF1C_MOUSE - +  NSFL1 cofactor p47 
TXND5_MOUSE - +  Thioredoxin domain-containing protein 5  
ASSY_MOUSE + +  Argininosuccinate synthase 
VATL_MOUSE + +  V-type proton ATPase 16 kDa proteolipid subunit 
ENOA_MOUSE + +  Alpha-enolase 
ACOT2_MOUSE - +  Acyl-coenzyme A thioesterase 2, mitochondrial 
NDUAD_MOUSE - + 
 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 13 
SCMC1_MOUSE - + 
 Calcium-binding mitochondrial carrier protein 
SCaMC-1 
OSTC_MOUSE + +  Oligosaccharyltransferase complex subunit OSTC 
ATPD_MOUSE - +  ATP synthase subunit delta, mitochondrial 
OLA1_MOUSE + +  Obg-like ATPase 1 
OST48_MOUSE - + 
 Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase 
KCRB_MOUSE + +  Creatine kinase B-type  
SUCB1_MOUSE - + 
 Succinyl-CoA ligase [ADP-forming] subunit beta, 
mitochondrial 
GTR1_MOUSE - + 
 Solute carrier family 2, facilitated glucose transporter 
member 1 
SOAT1_MOUSE - +  Sterol O-acyltransferase 1 
CA2D1_MOUSE + + 







3.4.2 Molecular Weight Classification 
The nature of our sample collection also included the property of molecular 
weight as a parameter to be investigated. Additionally, proteins of each band region 
were analyzed based on abundance. Protein abundance was quantitated using the 
emPAI protocol yielding values that reflect the number of observed peptides for a 
protein over the number of observable peptides (Ishihama et al 2005). MetaboAnalyst 
online program was used to visualize a direct comparison of protein abundance over 
time.  
  In band regions 1 and 2 at both 0 days and 6 days, a large number of cytoskeletal 
proteins were identified. Most of these proteins resided in band regions >212 kDa 
and ~212 kDa; identification of large, structural proteins was expected. However 
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there is enrichment of the smaller (~45 kDa) cytoskeletal and extracellular membrane 
factors in Day 6 relative to Day 0. These include desmin, reticulon-2, troponin, and 
tubulin. Also, high abundances of various isoforms of actin are enriched at both days. 
However, there is, in general, a higher abundance of these cytoskeletal factors at Day 
6 as the more complex myotubes are arranged. Titin, a protein of particular interest to 
us, was identified in day 0, but in low abundance and could not be considered in 
further analyses. 
Fig 3. Relative abundance of cytoskeletal proteins during development under 
high growth serum conditions. Arrows indicate myosin heavy chain isoforms, 
brackets indicate time and molecular weights. Relative abundance based on emPAI 
values.  
One of the more striking results is the temporal protein shift illustrated by Fig. 3 
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deals with myosin heavy chain isoforms. These isoforms are well characterized and 
each play a separate role during muscle development and post-natally. Myosin-9 and 
Myosin-10 are not traditional motor proteins, but aid in cytoskeletal remodeling thus 
are found in high abundance on both days. Myosin-3, an embryonic isoform is also 
found enriched on both days, as Day 6 is not yet considered post-natal (Kislinger et al 
2011). Myosin-7, the slow isoform, is present at both days, as well, although it should 
be noted Myosin-7 is also found in cardiac muscle. The drastic shifts can be observed 
in Myosin-8 and myosin-4. Myosin-8, perinatal isoform, shows high relative 
abundance at day 0, but seems to disappear at day 6; while myosin-4, a fast-twitch 
adult isoform, is highly expressed later in development. Also striking, is the presence 
Myosin-1, adult isoform, at Day 0; although its relative abundance increases at Day 
comparatively.    
Fig 4. Principal Coordinate Analysis (PCA) of Proteomic Data. PC's 1, 2 and 
3 describe over 90% variance between samples. Samples mainly cluster by molecular 
weight, as expected. As molecular weight of the samples decrease, there is more 
variance between samples. 
Although most proteins are present across the time points, an increase in cellular 
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function resulting in a higher diversity of proteins at day 6. At lower molecular 
weights, there is more variation between T= 0 and T= 6, especially in regulatory 
proteins, as the functional annotation above illustrates. These finding are further 
reflected in Fig. 3 There is less diversity among the larger proteins between time 
points, but much more diversity as molecular weight decreases. It is speculated the 
“average protein size” is 53 kDa; although with the diversity of proteins and gene 
expression, an average molecular weight seemd difficult to pinpoint, proteome shows 
more dynamics over time, as molecular weight decreases.  
3.4.3 Muscle Fiber Heterogeneity  
Lastly variations in proteins also indicates the presence of heterogenous muscle 
fibers, such as is the case with the presence of myocardial associated proteins such as, 
actin, alpha cardiac muscle, actin, aortic smooth muscle, and cardiotrophin like 
cytokine factor 1. Although our particular is on skeletal muscle fibers, this further 
indicates the complex nature of in vitro myogenesis and the lack of direct control 
over terminal differentiation program of the myoblasts.   
3.5 Gene expression  
As an extra step to confirm findings in our proteomic data, and asses mRNA 
expression over the course of development, RT-q-PCR was carried out on select 
genes. Our focus was on striated filament proteins in an attempt to discover more 
about the poorly understood sarcomere assembly. Genes for skeletal actin (alpha, 
actin-1), composing the thin filament of the sarcomere, myosin isoforms, composing 
the thick filaments, and skeletal isoform Titin N2A, spanning both thick and thin 
filaments for stability and elasticity, were amplified from total RNA of cells after a 
13 day time course with addition of high growth serum after initial withdrawal from 
the cell cycle (Appendix 3). 
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mRNA transcript levels were measured over a 12 day period at five distinct time 
points: control, 2 days, 6 days, 8 days, and 12 days. Control mRNA refers to 13 days 
of cell differentiation without addition of high growth serum. However, high growth 
factors post-differentiation were added back to at the respective time points to each 
cell culture, as per the previous time course. All cultures were collected after 13 days. 
Therefore, “2 days” can be interpreted as: 11 days with high growth serum treatment. 
“12 days” can be interpreted as: 1 day with high growth serum treatment. Because of 
the dynamic nature the myogenic program, relative gene expression was measured 
rather than absolute transcript levels. DART-PCR, an Excel based program, was used 
to measure relative variation among sample amplification. (Peirson et al. 2003)  
 
Fig 5. Relative fold change of Alpha Actin-1 expression. Measured mRNA 
transcript levels over time course. Time points indicate day high growth serum was 
added back  
Expression of skeletal actin stayed mostly consistent over time, despite 
addition of high growth serum. The proteome revealed skeletal actin to be highly 
abundant throughout terminal differentiation. These gene expression results are 
congruent with our previous findings. Titin N2A mRNA levels are elevated in 
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the control time course, sans addition of high growth serum, compared to 
experimental treatments. Addition of medium containing 20% FBS seems to 
reduce mRNA transcript levels of skeletal titin, even in day 12 in which culture 
contains high growth factors for only 1 day before collection. Although not 
significantly identified in our proteomic data, GO terms annotated to titin include 
sarcomere, actin-binding, and striated muscle contraction; these same terms are 
significant across both day 0 and day 6.  
 
 
Fig 6. Relative fold change in Titin N2A expression. Measured mRNA 
transcript levels over time course. Time points indicate day high growth serum was 
added back  
The proteome also revealed a striking shift in myosin isoforms throughout 
development; myosin is also an integral part of the sarcomere, fulling the 
functional requirements of muscle fibers. Myosin-8 was chosen due to its 
dramatic upregulation and decline over day 0 and day 6. Conversely, myosin-4 
was chosen to for its dramatic upregulation at day 6. Fig. 6 shows relative 
mRNA transcript levels for each myosin isoform. Like titin, myosin-4 and 
myosin-8 transcript levels are elevated during control time course relative to 
culture treated with high growth serum. However in the case of myosin-8, day 12 
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cells (1 day with high growth factor) show increase of mRNA transcripts; as well 
as, in myosin-4, day 12 cells show slight elevation of mRNA. Cells in the day 12 
cultures have spent the least time in the presence of high growth factor during 
terminal differentiation. Yet, these results do not reflect our findings from our 




Fig 7. Relative fold change in Myosin isoform expression. (A) Myosin-8 (B) 
Myosin-4. Measured mRNA transcript levels over time course. Time points indicate 







Although embryonic myogenesis has been well defined, the in vitro myogenic 
program must also be mapped out in such detail. Traditionally, myogenic regulation 
has been investigated by knock-out/down/in genetic experiments, trailing only few 
transcription factors at a time. Muscle tissue is also often extracted directly from 
mice, rats, chickens, and other organisms; and although the tissue is cultivated in a 
living system, extraction methods can be difficult and the quality and quantity of 
protein, DNA, and RNA can be very limited. Cell culture technique offers a quick 
and relatively simple solution to investigating a living system. With the emergence of 
high-throughput technologies and biocomputational tools, systems biology will help 
further define developmental processes in vitro.. 
4.2 In vitro Myogenesis  
Characterization of our proteome revealed in vitro late myogensis to be 
congruent with myogenic progression in vivo. With the use of C2C12 cells we forgo 
early phases of myogenesis such as lineage establishment and begin at differentiation. 
There is no true migration of cells in culture, but the embryonic myoblasts do 
maintain their proliferative properties so long as they are fed growth factors. 
Differentiation is artificially triggered with withdrawal of growth serum. C2C12 cells 
exit the cell cycle and begin to fuse to form mature myocytes. This switch in global 
programs was of most interest to us.  
4.2.1 High Growth Serum Add-Back  
In addition to allowing cells to grow for 13 days, we took a novel approach by 
adding back mitogens post-differentiation by adding high levels of growth serum to 
media. Our original hypothesis indicating high levels of mitogens would affect the 
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transcriptional cascade of the cells in culture. However, our proteomic data indicated 
addition of mitogens and growth factors post-induction of differentiation did not 
affect the myogenic program. It seems once these signaling cascades are triggered, 
they cannot be reset. To further support this hypothesis we see an absence of proteins 
from both the Notch signaling pathway and the SMAD signaling pathway; both 
negative regulators of myogensis. Their role in vivo is to keep progenitor cells in a 
proliferative state accounting for the presence of satellite cells for post-natal muscle 
development (Braun,Gautel et al 2011). Although our sampling relied on molecular 
weight, both NOTCH3 and SMAD4 at 205 kDa and 48 kDa, respectively, would 
have conceivably been within selected band regions if present.  
More evidence for the contrary to our original hypothesis is the elevated 
expression of alpha-enolase. Initially thought of solely in its glycolytic role, 
alpha-enolase converts the precursor 2-phosphoglycerate to phosphoenolpyruvate in 
the ninth step in glycolysis (Subramanian, Miller, 2000). However, alpha-enolase is 
elevated at day 0, as well; seeming to be early expression compared to other 
advanced metabolic machinery. ENO1, the gene coding for the enzyme also codes 
for myc-binding protein-1 (MBP1) which binds and downregulates the activity of 
c-myc. C-myc is a well-studied transcription factor directly involved in DNA 
replication and cell proliferation. C-myc is activated by mitogenic factors, such as 
those found in fetal bovine serum, through the mitogen activated protein kinase 
pathway (MAPK pathway) which is well documented to be upregulated during early 
myogenesis. The artificial addition of mitogens were not enough to activate the, 
most-likely, bound c-myc within the developing myoblasts (Subramanian, Miller 
200). Our revised hypothesis is the myogenic program in vitro is irreversible once 
terminal differentiation has been induced.  
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4.2.2. Proteomic Evidence of Myogenic Progression  
A hierarchical expression of proteins reflecting significant events revealed itself 
upon functional annotation. Firstly, the presence of basic transcriptional regulators 
such as histones and DNA topoisomerase 2-beta which affect DNA accessibility and 
methylation which functions in alternatively splicing. These events most likely lead 
to the translation of new proteins necessary for further development of the myotube. 
Alternatively, the presence of signaling proteins such as Ras GTPase activating like 
protein and A anchor protein kinase 2 indicate a regulatory function, as well as 
creation of new cell machinery. Ras GTPase activating like protein is a late 
downstream target of Ras, which activates other pathways during myogenesis. This 
protein is thought to participate in actin reorganization during remodeling (Kislinger 
et al. 2005). An anchor protein kinase 2 binds the subunit protein kinase A (PKA) 
which acts through cAMP for downstream signaling and may play a role in 
functional regulation of ion channels (Shwartz, 2011).   
The most obvious class of proteins to participate in myogensis is cytoskeletal 
elements. Although we only identified 210 total proteins compared to Kislinger et al 
who found ~2000 proteins; both our proteome and their proteome is predominantly 
cell remodeling and organizational agents such as proteases, cytoskeletal proteins, 
adhesion proteins, and extracellular membrane proteins. Not only are these classes of 
proteins functionally enriched according to their GO terms annotations, but they as 
Fig. 2 shows, their spectral counts were most abundant according to their emPAI’s.  
The other notable class of proteins that are upregulated upon mature myofiber 
formation are involved in the biochemical pathways to create energy to allow 
muscles to contract. ATP binds the myosin II motor protein in the sarcomere; these 
motor proteins have ATPase domains. Upon the hydrolysis of ATP, myosin move 
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along actin filaments to produce contraction. Proteins such as cytochrome b-c1 
complex subunits indicate the assembly of the electron transport chain crucial for 
abundant ATP synthesis. Other major metabolic enzymes enriched, include citrate 
synthase which participates in the first step of the citric acid cycle for the total 
breakdown of glucose and creatine kinase which functions to form ATP from 
creatine. 
Unexpectedly we also found a significant number of ribosomal proteins, such as 
60s ribosomal protein L31, 40s ribosomal protein s19, etc. (Table 5). These proteins 
appeared at both time points, and most had relatively high emPAI values. Whilst 
functionally annotating the proteome, common GO terms associated with these 
proteins were RNA-binding, translation, and ribosome. In fact, the highest GO 
enrichment score, according to DAVID analysis, was for translation. In recent years, 
more research has been done in post-transcriptional regulation of gene levels by 
microRNA (miRNA’s) (Braun, Gautel, 2011). These bind to transcription factors, 
modulating further downstream application. More research is being done on their 












Table 5. Ribosomal proteins. Proteins identified as ribosomal compartments or 
RNA-binding proteins. “+” represents presence of protein at Day 0 and Day 6 , and “-” 
represents absence of protein at Day and Day 6.    
    
Uniprot ID Day 0 Day 6 Protein names 
RLA2_MOUSE + + 60S acidic ribosomal protein P2 
RL22_MOUSE + + 
60S ribosomal protein L22 (Heparin-binding protein 
HBp15) 
RS16_MOUSE + + 40S ribosomal protein S16 
RS19_MOUSE + + 40S ribosomal protein S19 
RL3_MOUSE + + 60S ribosomal protein L3 (J1 protein) 
RL30_MOUSE + + 60S ribosomal protein L30 
IF5A1_MOUSE + + 
Eukaryotic translation initiation factor 5A-1 
(eIF-5A-1) 
RS27A_MOUSE + + Ubiquitin-40S ribosomal protein S27a 
RS26_MOUSE + + 40S ribosomal protein S26 
RL34_MOUSE + - 60S ribosomal protein L34 
RL23_MOUSE + + 60S ribosomal protein L23 
RL4_MOUSE + + 60S ribosomal protein L4 
EIF3A_MOUSE + + 
Eukaryotic translation initiation factor 3 subunit A 
(eIF3a) 
U520_MOUSE + + U5 small nuclear ribonucleoprotein 200 kDa helicase 
RL31_MOUSE + + 60S ribosomal protein L31 
RS20_MOUSE - + 40S ribosomal protein S20 
IF4A1_MOUSE + + Eukaryotic initiation factor 4A-I (eIF-4A-I)  
RRBP1_MOUSE + + 
Ribosome-binding protein 1 (Ribosome receptor 
protein)  
SMCA4_MOUSE + - Transcription activator BRG1  
 
4.3 Sarcomeric Gene expression  
Transcription during any development process is highly diverse, complex, and 
dynamic; an attempt to measure the transcription of all genes would prove a lofty 
goal. However, we focused on the process of sarcomerogenesis, and therefore chose 
to measure mRNA transcript levels for skeletal titin, alpha actin, skeletal, and 
myosin.  
A model for sarcomere formation exists describing titin as a scaffold that binds 
transiently formed Z-lines, as a first step. The elevated titin expression level during 
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the control time course (no addition of high growth factors), is congruent with this 
model as several new sarcomeres form in the cell culture (Rui et al 2010). Addition 
of high growth factors, even for 24 hours (Day 12) seems to downregulate 
transcription of the gene. TTN is a large gene with several transcription factor 
binding sites; any one of these diverse transcription factors are elements in additional 
signaling pathways which may be directly affected by the addition of mitogens and 
indirectly affect TTN transcription (Zhang et al 2003) 
Contrarily, skeletal actin relative expression remained constant consistent with 
our proteomic findings. At both Days 0 and Days 6, cytoskeletal proteins served as 
evidence of drastic actin cytoskeletal remodeling which accounts for the consistently 
elevated levels of actin. Alternatively, alpha-actin gene expression is under regulation 
of the serum response growth factor (SRF) which in turn is downtream element in the 
MAPK pathway which is involved in both cell proliferation and differentiation. For 
this reason, the addition of high growth serum may not have negatively impacted 
expression. Further alpha-actin is shown to recruit myogenic elements once 
upregulated, accounting for the presence proper myogensis-associated proteins in our 
proteomic data. (Gunning et al 2000) 
Lastly, our results for myosin seemed more ambigous, as they were not 
consistent with our observations in the proteome. However, myosin is a highly 
conserved protein with several paralogs; therefore mRNA levels in the results may 
have reflected accidental amplification of other isoforms. Myosin isoforms are found 
in a gene cluster on chromosome 11 in mice; the regulation of transcription of each 
isoform according to its respective environmental or temporal stiumli has not been 
elucidated. (Weiss et al 1999) Added external growth factors may have directly or 
indirectly affected this transcription.  
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 Myogensis is a prolific process including countless signaling pathways with a 
series of checks and balances. It is possible the add back of mitogens may have 
altered the transcription of very specific genes, however, post-transcriptional and 
post-translation regulation may have prevented an altered proteomic result. 
Regulation, after all, is present to correct for abnormalities in any complex program 
(Puente et al 2004)  
4.4 Limitations 
There are unfortunately, some limitations in our methodologies due mainly to 
cost. For example, only two time points were chosen for proteomic analysis; ideally, 
the inclusion of more time points in our investigation would allow for the discovery 
of more specific processes along the myogenic program. Additionally, gel 
electrophoresis, although not discriminatory to protein type, depends on the proteins 
electrophoretic mobility which is hindered by giant proteins or conversely very small 
proteins may have run off the gel. Selecting proteins for identification based on four 
molecular weights and protein solubility may have limited our total protein diversity.  
Many vital myogenic factors were not detected such as members from the MRF 
transcription factor family, or a member from the paired homeobox transcription 
factors. For example Myogenin at 25 kDa and Pax7 at 54 kDa, both important for 
terminal differentiation, may have been present in the cell lysate but fell outside 
selected band regions, or were not included in the detergent-insoluble fraction of the 
total cell lysate. A protein profile from a proliferative myoblast would have been 
helpful, as well, to directly reflect on the global change immediately prior to 
differentiation.   
4.5 Future work 
We will continue looking into the dynamics of the myogenic proteome and 
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sarcomeric gene expression. The detergent-insoluble fraction of the cell lysate has 
been filtered to increase likelihood of titin detection. Titin was identified through 
MASCOT in our first set of proteomic data, however it received an emPAI value of 
0.00 and could not be considered in our analysis. As titin is a giant protein, its 
electrophoretic mobility is limited. Bands at >212 kDa from all time points have been 
selected and sent to the Ohio State University Mass Spectroscopy facility. Data will 
be functionally annotated in the same fashion as our data discussed here.  
Efforts are also being put forth to more accurately measure mRNA transcript 
levels of isoforms of myosin. Our previous approach included a one-step RT-qPCR 
methodology; however, we are generating cDNA from total RNA extracted from 
developing cells. qPCR will be carried out on the cDNA, and data will be analyzed 
through DART-PCR. Also crucial for accurate measurement of relative gene 
expression is the inclusion of a housekeeping gene; we are developing a reliable 
housekeeping gene for our system. With the tumultuous intracellular signaling 
processes during development, finding a gene with a constant level of expression 
proves difficult (Jeong et al 2014). So far this study has provided a road map of 
essential events in the myogenic program, using an in vitro approach. This will allow 
for more targeted studies in the future as events in cell culture will be easier to 
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A1. Materials  
 
Mammalian Cell Culture  
Product Manufacturer 
C2C12 (ATCCR CRL-1772™) American Type Culture Collection (ATCC) 
Manassas, VA 
Dublecco’s Modified Eagle’s Media 
(DMEM)  
American Type Culture Collection (ATCC) 
Manassas, VA 
Medium 199 BioWhittaker 
Walkersville, MD 








Gel Electrophoresis  
Product Manufacturer 
Criterion TGX 12% 1mm Gel Bio-Rad Laboratories 
Hercules, CA 












Pharos FX Plus Molecular Imager Bio-Rad Laboratories 
Hercules, CA 
















RNA extraction and PCR 
Products Manufacturer 
RNeasy Mini Kit Qiagen, Inc. 
Valencia, CA 
OneStep RT-PCR Kit Qiagen, Inc. 
Valencia, CA 
iTaqtm Universal SYBR® Green One- 








iCylcer Bio-Rad Laboratories 
Hercules, CA 








Miscellaneous Chemicals and Equipment 
Product Manufacturer 
Coomaissee Brilliant Blue R-250 Fisher Scientific 
Pittsburgh, PA 
Glacial acetic acid  
Protease inhibitor tablet Roche, USA 
San Francisco, CA 
Sodium dodecyl sulfate (SDS) Amresco Corporation, 
Solon, OH 
Triton-X-100 Sigma-Aldrich Corporation,  
St. Louis, MO 
Equipment Manufacturer 
Olympus LH 50A Inverted Phase 
Contrast Microscope 
Olympus America, 



















A2. Solutions and Media 
 
Mammalian Cell Culture 
Media Recipe 
High Serum Growth Media 790mL DMEM 
200mL FBS 
10mL antibiotic 





Cell Lysate Extraction 
Solution Recipe 
4X SDS Sample Buffer 12.5 g glycerol 
0.76 g tris base 
2.30 g SDS 
12.3 ml 0.5 M hydrochloric acid 
17.75 ml deionized water 
Isotonic Wash Buffer 1.211 g tris base 
0.406 g magnesium chloride 
heptahydrate 
51.345 g sucrose 
500 ml deionized water 
Adjust pH to 7.4 
Triton-x-100 Extraction Buffer 100 ml Isotonic Wash Buffer 
0.5 ml Triton X-100 
protease inhibitor tablet 
 
 
Gel Eletrophoresis and Analysis 
Solution Recipe 
Tris-Glycine-SDS Running Buffer (TGS) 800 ml deionized water 
30.2 g tris base 
10.0 g SDS 
188 glycine 
Coomassie Stain 2.5 g Coomassie Brilliant Blue R-250 
100 ml Glacial Acetic Acid 
450 Methanol 
450 ml H20 
High Destain 100 ml glacial acetic acid 
400 ml methanol 
500 ml deionized water 
Low Destain 100 ml glacial acetic acid 
150 ml methanol 






A3. Time Course Calendars  
 
Proteomics Time Course Calendar (13 Days) 
Sample Time Point No. Of Days Treated with High 
Serum Add-back  
Day of Harvest 
Day 0 None Day 1 
Day 2 11 Days Day 13 
Day 4 9 Days Day 13 
Day 6 7 Days Day 13 
Day 8 5 Days Day 13 




Gene Expression Time Course Calendar (13 Days) 
Sample Time Point No. Of Days Treated with 
High Serum Add-back 
Day of Harvest 
Control None Day 13 
Day 2 11 Days Day 13 
Day 4 9 Days Day 13 
Day 6 7 Days Day 13 
Day 8 5 Days Day 13 





























A4. Bioinformatic Online Resources 
 
Databse/Software Website 





Gene Ontology Consortium http://geneontology.org/ 












































A5. Proteomic Data 
  
Day 0   
Uniprot ID Protein emPAI 
RS27A_MOUSE  Ubiquitin-40S ribosomal protein S27a 0.4 
ACTB_MOUSE  Actin, cytoplasmic 1  0.35 
NEST_MOUSE  Nestin 0.32 
TBA1A_MOUSE  Tubulin alpha-1A chain 0.29 
H2B1B_MOUSE  Histone H2B type 1-B 0.29 
CLH1_MOUSE  Clathrin heavy chain 1  0.29 
HNRPD_MOUSE  Heterogeneous nuclear ribonucleoprotein 0.28 
RS26_MOUSE  40S ribosomal protein S26 0.26 
ACTA_MOUSE  Actin, aortic smooth muscle 0.25 
RL34_MOUSE  60S ribosomal protein L34 0.25 
ACTBL_MOUSE  Beta-actin-like protein 2 0.25 
MAP4_MOUSE  Microtubule-associated protein 4  0.24 
RL23_MOUSE  60S ribosomal protein L23 0.23 
HNRPF_MOUSE  Heterogeneous nuclear ribonucleoprotein F 0.23 
VATL_MOUSE  V-type proton ATPase 16 kDa proteolipid subunit 0.22 
RL4_MOUSE  60S ribosomal protein L4 0.22 
H3C_MOUSE  Histone H3.3C 0.22 
TOM20_MOUSE 
 Mitochondrial import receptor subunit TOM20 
homolog 
0.21 
OSTC_MOUSE  Oligosaccharyltransferase complex subunit OSTC 0.2 
IF1AX_MOUSE  Eukaryotic translation initiation factor 1A 0.2 
CISY_MOUSE  Citrate synthase, mitochondrial 0.2 
VIME_MOUSE  Vimentin  0.2 
RS27A_MOUSE  Ubiquitin-40S ribosomal protein S27a 0.18 
MYH10_MOUSE  Myosin-10 0.17 
TBB5_MOUSE  Tubulin beta-5 chain 0.14 
SPTN1_MOUSE  Spectrin alpha chain, non-erythrocytic 1 0.13 
CLCF1_MOUSE  Cardiotrophin-like cytokine factor 1  0.13 
MYH8_MOUSE  Myosin-8  0.12 
TOP2B_MOUSE  DNA topoisomerase 2-beta 0.11 
TLN1_MOUSE  Talin-1  0.1 
FLNC_MOUSE  Filamin-C 0.1 
RRBP1_MOUSE  Ribosome-binding protein 1 0.08 
ILF2_MOUSE  Interleukin enhancer-binding factor 2  0.08 
RBMX_MOUSE  RNA-binding motif protein, X chromosome 0.08 
KCRB_MOUSE  Creatine kinase B-type 0.08 
ASSY_MOUSE  Argininosuccinate synthase 0.07 
TADBP_MOUSE  TAR DNA-binding protein 43  0.07 
SERPH_MOUSE  Serpin H1 0.07 
PSMD6_MOUSE  26S proteasome non-ATPase regulatory subunit 6  0.07 
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INF2_MOUSE  Inverted formin-2 0.07 
FLNB_MOUSE  Filamin-B 0.07 
PGBM_MOUSE 
 Basement membrane-specific heparan sulfate 
proteoglycan core protein 
0.06 
SPTB2_MOUSE  Spectrin beta chain, non-erythrocytic 1 0.06 
DYHC1_MOUSE  Cytoplasmic dynein 1 heavy chain 1 0.06 
CA2D1_MOUSE 
 Voltage-dependent calcium channel subunit 
alpha-2/delta-1  
0.06 
NID2_MOUSE  Nidogen-2 0.04 
EIF3A_MOUSE  Eukaryotic translation initiation factor 3 subunit A 0.04 
RTN4_MOUSE  Reticulon-4 0.03 
U520_MOUSE 
 U5 small nuclear ribonucleoprotein 200 kDa 
helicase 
0.03 
IQGA1_MOUSE  Ras GTPase-activating-like protein  0.03 
AKAP2_MOUSE  A-kinase anchor protein 2  0.03 
PRP8_MOUSE  Pre-mRNA-processing-splicing factor 8 0.02 
MACF1_MOUSE  Microtubule-actin cross-linking factor 1 0.02 
SMCA4_MOUSE  Transcription activator BRG1 0.02 
FBLN2_MOUSE  Fibulin-2 0.02 
TPR_MOUSE  Nucleoprotein TPR 0.01 
 
DAY 6   
Uniprot ID Protein  emPAI 
ACTB_MOUSE  Actin, cytoplasmic 1 14.22 
PPIA_MOUSE  Peptidyl-prolyl cis-trans isomerase A  9.96 
ACTC_MOUSE  Actin, alpha cardiac muscle 1  8.56 
ACTS_MOUSE  Actin, alpha skeletal muscle 8.5 
RLA2_MOUSE  60S acidic ribosomal protein P2 5.11 
H2A2B_MOUSE  Histone H2A type 2-B 4.73 
MYH9_MOUSE  Myosin-9  3.4 
H2A1F_MOUSE  Histone H2A type 1-F 2.63 
MLRS_MOUSE 
 Myosin regulatory light chain 2, skeletal muscle 
isoform 
2.12 
MYH3_MOUSE  Myosin-3 2.08 
RL22_MOUSE  60S ribosomal protein L22 1.82 
EF1A1_MOUSE  Elongation factor 1-alpha 1  1.76 
RS16_MOUSE  40S ribosomal protein S16 1.54 
H2B1B_MOUSE  Histone H2B type 1-B 1.39 
RL31_MOUSE  60S ribosomal protein L31 1.33 
RS19_MOUSE  40S ribosomal protein S19 1.15 
SERPH_MOUSE  Serpin H1 0.98 
NEST_MOUSE  Nestin 0.88 
H3C_MOUSE  Histone H3.3C 0.82 
H32_MOUSE  Histone H3.2  0.82 
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IQGA1_MOUSE  Ras GTPase-activating-like protein IQGAP1 0.79 
RL3_MOUSE  60S ribosomal protein L3  0.73 
QCR2_MOUSE  Cytochrome b-c1 complex subunit 2, mitochondrial 0.7 
MYH7_MOUSE  Myosin-7 0.61 
MYH1_MOUSE  Myosin-1 0.61 
FLNA_MOUSE  Filamin-A 0.58 
CISY_MOUSE  Citrate synthase, mitochondrial 0.54 
FINC_MOUSE  Fibronectin 0.51 
H31_MOUSE  Histone H3.1 0.48 
TOM20_MOUSE 
 Mitochondrial import receptor subunit TOM20 
homolog 
0.45 
NDKA_MOUSE  Nucleoside diphosphate kinase A 0.43 
PLEC_MOUSE  Plectin 0.42 
HNRPF_MOUSE  Heterogeneous nuclear ribonucleoprotein F 0.41 
ATPB_MOUSE  ATP synthase subunit beta, mitochondrial 0.41 
TNNC1_MOUSE  Troponin C, slow skeletal and cardiac muscles 0.4 
RS27A_MOUSE  Ubiquitin-40S ribosomal protein S27a  0.4 
QCR1_MOUSE  Cytochrome b-c1 complex subunit 1, mitochondrial 0.35 
ACTA_MOUSE  Actin, aortic smooth muscle 0.35 
CLH1_MOUSE  Clathrin heavy chain 1 0.33 
DNJA2_MOUSE  DnaJ homolog subfamily A member 2 0.32 
ANXA7_MOUSE  Annexin A7 0.29 
HNRPD_MOUSE  Heterogeneous nuclear ribonucleoprotein 0.28 
FLNC_MOUSE  Filamin-C 0.27 
RS26_MOUSE  40S ribosomal protein 0.26 
RL30_MOUSE  60S ribosomal protein L30 0.26 
SEPT2_MOUSE  Septin-2  0.26 
NSF1C_MOUSE  NSFL1 cofactor p47 0.26 
RS20_MOUSE  40S ribosomal protein S20 0.25 
TFR1_MOUSE  Transferrin receptor protein 1 0.25 
TXND5_MOUSE  Thioredoxin domain-containing protein 5  0.23 
RL23_MOUSE  60S ribosomal protein L23 0.23 
ASSY_MOUSE  Argininosuccinate synthase 0.23 
PRS8_MOUSE  26S protease regulatory subunit 0.23 
PSD11_MOUSE  26S proteasome non-ATPase regulatory subunit 11 0.22 
MYH3_MOUSE  Myosin-3  0.22 
VATL_MOUSE  V-type proton ATPase 16 kDa proteolipid subunit 0.22 
PRS7_MOUSE  26S protease regulatory subunit 7 0.22 
ENOA_MOUSE  Alpha-enolase 0.22 
ARP3_MOUSE  Actin-related protein 3 0.22 
 RS14_MOUSE  40S ribosomal protein S14 0.21 
ACOT2_MOUSE  Acyl-coenzyme A thioesterase 2, mitochondrial 0.21 
VIME_MOUSE  Vimentin 0.2 
NDUAD_MOUSE  NADH dehydrogenase [ubiquinone] 1 alpha 0.2 
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subcomplex subunit 13 
IF5A1_MOUSE  Eukaryotic translation initiation factor 5A-1  0.2 
CALM_MOUSE  Calmodulin 0.2 
VIME_MOUSE  Vimentin  0.2 
SCMC1_MOUSE 
 Calcium-binding mitochondrial carrier protein 
SCaMC-1 
0.2 
OSTC_MOUSE  Oligosaccharyltransferase complex subunit OSTC 0.2 
ATPD_MOUSE  ATP synthase subunit delta, mitochondrial 0.19 
IF4G1_MOUSE  Eukaryotic translation initiation factor 4 gamma 1 0.18 
ACTA_MOUSE  Actin, aortic smooth muscle 0.16 
TADBP_MOUSE  TAR DNA-binding protein 43 0.15 
OLA1_MOUSE  Obg-like ATPase 1 0.15 
MYH10_MOUSE  Myosin-10  0.15 
RL4_MOUSE  60S ribosomal protein L4 0.14 
FLNB_MOUSE  Filamin-B 0.14 






 Basic leucine zipper and W2 domain-containing 
protein 1 
0.14 
DESM_MOUSE  Desmin 0.13 
INF2_MOUSE  Inverted formin-2 0.12 
TLN1_MOUSE  Talin-1  0.11 
PGBM_MOUSE 
 Basement membrane-specific heparan sulfate 
proteoglycan core protein 
0.11 
SPTN1_MOUSE  Spectrin alpha chain, non-erythrocytic 1 0.11 
TNNT2_MOUSE  Troponin T, cardiac muscle 0.09 
NID2_MOUSE  Nidogen-2  0.09 
MAK16_MOUSE  Protein MAK16 homolog 0.09 
DYHC1_MOUSE  Cytoplasmic dynein 1 heavy chain 1 0.09 
SPB6_MOUSE  Serpin B6 0.08 
RTN4_MOUSE  Reticulon-4 0.08 
MYH4_MOUSE  Myosin-4 0.08 
DAZP1_MOUSE  DAZ-associated protein 1 0.08 
APJ_MOUSE  Apelin receptor 0.08 
KCRB_MOUSE  Creatine kinase B-type  0.08 
ACTY_MOUSE  Beta-centractin 0.08 
TOP2B_MOUSE  DNA topoisomerase 2-beta 0.07 
TBL2_MOUSE  Transducin beta-like protein 2 0.07 
SNF5_MOUSE 
 SWI/SNF-related matrix-associated actin-dependent 
regulator of chromatin subf 
0.07 
ENOA_MOUSE  Alpha-enolase  0.07 
EF2_MOUSE  Elongation factor 2 0.07 
U520_MOUSE  U5 small nuclear ribonucleoprotein 200 kDa helicase 0.07 
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TBB5_MOUSE  Tubulin beta-5 chain 0.07 
SUCB1_MOUSE 
 Succinyl-CoA ligase [ADP-forming] subunit beta, 
mitochondrial 
0.07 
IF4A1_MOUSE  Eukaryotic initiation factor 4A-I 0.07 
CTBP1_MOUSE  C-terminal-binding protein 1 0.07 
TBA1B_MOUSE  Tubulin alpha-1B chain 0.06 
PPGB_MOUSE  Lysosomal protective protein 0.06 
MAP4_MOUSE  Microtubule-associated protein 4 0.06 
LMAN1_MOUSE  Protein ERGIC-53 0.06 
GTR1_MOUSE 
 Solute carrier family 2, facilitated glucose transporter 
member 1 
0.06 
COR1C_MOUSE  Coronin-1C 0.06 
SEPT7_MOUSE  Septin-7 0.06 
NEST_MOUSE  Nestin 0.06 
MYOF_MOUSE  Myoferlin 0.06 
SOAT1_MOUSE  Sterol O-acyltransferase 1 0.05 
GPC1_MOUSE  Glypican-1  0.05 
VIGLN_MOUSE  Vigilin 0.05 
FBLN2_MOUSE  Fibulin-2 0.05 
CLH1_MOUSE  Clathrin heavy chain 1 0.05 
PRP8_MOUSE  Pre-mRNA-processing-splicing factor 8 0.04 
MYH7_MOUSE  Myosin-7 0.04 
HNRPU_MOUSE  Heterogeneous nuclear ribonucleoprotein U 0.04 
MYH10_MOUSE  Myosin-10 0.04 
LMNA_MOUSE  Prelamin-A/C 0.04 
TLN2_MOUSE  Talin-2 0.03 
MYOF_MOUSE  Myoferlin 0.03 
CHD5_MOUSE  Chromodomain-helicase-DNA-binding protein 5 0.03 
 RTN4_MOUSE  Reticulon-4 0.03 
 MAP4_MOUSE  Microtubule-associated protein 4 0.03 
CA2D1_MOUSE 
 Voltage-dependent calcium channel subunit 
alpha-2/delta-1  
0.03 
LAMB1_MOUSE  Laminin subunit beta-1 0.02 
KTN1_MOUSE  Kinectin 0.02 
 SPTB2_MOUSE  Spectrin beta chain, non-erythrocytic 1 0.02 
 RRBP1_MOUSE  Ribosome-binding protein 1 0.02 
 PLEC_MOUSE  Plectin 0.02 
 MRC2_MOUSE  C-type mannose receptor 2 0.02 
 FLNA_MOUSE  Filamin-A 0.02 
 EIF3A_MOUSE  Eukaryotic translation initiation factor 3 subunit A  0.02 
 ECM29_MOUSE  Proteasome-associated protein ECM29 homolog 0.02 
U520_MOUSE  U5 small nuclear ribonucleoprotein 200 kDa helicase 0.01 
TPR_MOUSE  Nucleoprotein TPR 0.01 
RBP2_MOUSE  E3 SUMO-protein ligase RanBP2 0.01 
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MAP1B_MOUSE  Microtubule-associated protein 1B 0.01 
TLN1_MOUSE  Talin-1  0.01 
MYH9_MOUSE  Myosin-9 0.01 
MACF1_MOUSE  Microtubule-actin cross-linking factor 1 0.01 
 
 
 
 
